Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification.
Saatci O, Akbulut O, Cetin M, Sikirzhytski V, Uner M, Lengerli D, O'Quinn EC, Romeo MJ, Caliskan B, Banoglu E, Aksoy S, Uner A, Sahin O.
Saatci O, et al. Among authors: banoglu e.
Cell Death Differ. 2023 May;30(5):1305-1319. doi: 10.1038/s41418-023-01140-1. Epub 2023 Mar 2.
Cell Death Differ. 2023.
PMID: 36864125
Free PMC article.